Guided Therapeutics (GTHP) Change in Account Payables (2016 - 2021)

Guided Therapeutics' Change in Account Payables history spans 11 years, with the latest figure at -$84000.0 for Q2 2021.

  • On a quarterly basis, Change in Account Payables fell 197.67% to -$84000.0 in Q2 2021 year-over-year; TTM through Jun 2021 was -$446000.0, a 4560.0% decrease, with the full-year FY2020 number at -$372000.0, down 1960.0% from a year prior.
  • Change in Account Payables hit -$84000.0 in Q2 2021 for Guided Therapeutics, down from $29000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for GTHP hit a ceiling of $148000.0 in Q1 2017 and a floor of -$208000.0 in Q3 2020.
  • Historically, Change in Account Payables has averaged $388.89 across 5 years, with a median of $20500.0 in 2018.
  • Biggest five-year swings in Change in Account Payables: soared 353.33% in 2019 and later plummeted 730.3% in 2020.
  • Tracing GTHP's Change in Account Payables over 5 years: stood at $54000.0 in 2017, then dropped by 22.22% to $42000.0 in 2018, then tumbled by 200.0% to -$42000.0 in 2019, then crashed by 335.71% to -$183000.0 in 2020, then surged by 54.1% to -$84000.0 in 2021.
  • Business Quant data shows Change in Account Payables for GTHP at -$84000.0 in Q2 2021, $29000.0 in Q1 2021, and -$183000.0 in Q4 2020.